Roledumab Explained

Roledumab is a monoclonal antibody. It binds to RHD, the Rhesus factor antigen.[1] [2]

It is currently at Phase III trials for Rh disease.

Notes and References

  1. . International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 103 . WHO Drug Information . 2010 .
  2. Kaplon H, Reichert JM . Antibodies to watch in 2018 . mAbs . 10 . 2 . 183–203 . 2018 . 29300693 . 5825203 . 10.1080/19420862.2018.1415671 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Roledumab".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.